Alendronate stays in your body far longer than most medications. While it clears from your bloodstream within hours of taking a dose, the drug embeds itself in your bones and remains there for years. The FDA estimates alendronate’s terminal half-life in bone exceeds 10 years, meaning it takes over a decade for your skeleton to release even half of the accumulated drug.
Why Alendronate Stays So Long
Alendronate belongs to a class of drugs called bisphosphonates, which have an unusually strong chemical attraction to bone mineral. When you swallow a tablet, the portion that makes it into your bloodstream quickly travels to your skeleton and locks onto hydroxyapatite, the calcium-rich crystals that give bones their hardness. The drug’s molecular structure includes phosphate groups that grip these crystals tightly, with an additional component that further strengthens the bond to calcium.
Once embedded, alendronate stays put until the bone it’s attached to is naturally broken down and rebuilt, a process called remodeling. Since bone turnover is slow (and since alendronate itself slows it further), the drug gets released back into your system only gradually over many years. Any alendronate that doesn’t find a binding site in bone is cleared rapidly through the kidneys. Renal excretion is the only way the body eliminates the drug, so people with impaired kidney function retain more of it in both their blood and bones.
Blood Levels vs. Bone Levels
There’s an important distinction between how long alendronate circulates in your blood and how long it persists in your skeleton. After you take a dose, blood levels drop quickly as the drug either binds to bone or gets filtered out by the kidneys. Within hours, very little remains in circulation. But the portion stored in bone creates a deep reservoir that slowly leaches back out over the following years.
This is why the drug keeps working even after you stop taking it. Your bones continue releasing small amounts of alendronate during normal remodeling, which continues to suppress the cells that break down bone. The protective effect doesn’t vanish the day you stop your prescription.
Very Little Actually Gets Absorbed
Only a tiny fraction of each pill enters your body. The average oral bioavailability of alendronate is just 0.64%, meaning more than 99% of the dose passes through your digestive tract without being absorbed. That fraction drops even further if you eat or drink anything too soon. Taking alendronate just 30 minutes to one hour before breakfast instead of the recommended two hours reduces absorption by about 40%. Coffee or orange juice taken at the same time cuts it by roughly 60%, and eating a meal alongside the pill makes absorption essentially zero.
This is why the dosing instructions are so strict: take it first thing in the morning on an empty stomach with plain water, then wait at least 30 minutes (ideally two hours) before eating or drinking anything else. Despite the low absorption rate, the drug accumulates in bone over months and years of treatment, building up a significant reservoir.
How Long the Effects Last After Stopping
Because of that bone reservoir, alendronate’s fracture-preventing benefits persist well after you stop taking it. This is the basis for “drug holidays,” planned breaks from treatment that many doctors recommend after several years of use. Current guidance suggests reassessing whether you still need alendronate after five years of oral treatment. If your fracture risk is no longer high, your doctor may recommend stopping for one to two years before deciding whether to restart.
The logic is straightforward: the drug stored in your skeleton keeps suppressing bone breakdown during the holiday, so you don’t immediately lose the protection you’ve built up. How long that residual effect lasts depends on your individual bone turnover rate, your age, and how much drug has accumulated. For alendronate specifically, a holiday of about two years is the typical recommendation, compared to one year for some other bisphosphonates and three years for the intravenous form (zoledronic acid), reflecting differences in how tightly each drug binds and how much accumulates.
Why Long-Term Retention Matters
The flip side of alendronate’s persistence is that it can cause problems with prolonged use. The most discussed risk is atypical femoral fracture, an unusual break in the thighbone that occurs in a different pattern than a normal osteoporosis fracture. These are rare but become more likely the longer you’ve been on the drug. After three or more years of use, the risk starts climbing. Beyond five years, it increases substantially, with one study finding the odds nearly tripled compared to shorter use.
To put the absolute numbers in perspective: for people in their first two years of treatment, atypical fracture rates run about 1.8 per 100,000 per year. For those who’ve been on bisphosphonates eight to ten years, that number rises to roughly 113 per 100,000 per year. The risk is still small in absolute terms, but it’s the primary reason guidelines now recommend periodic reassessment rather than indefinite treatment.
The concern is that years of suppressed bone remodeling can make bones more brittle in a specific way. Normal bone constantly repairs tiny stress fractures through remodeling. When that process is heavily suppressed for too long, microdamage can accumulate, particularly in the thighbone where repetitive stress is highest. Drug holidays allow remodeling to partially resume, potentially reducing this risk while the stored drug continues providing some protection against the more common osteoporotic fractures.
Factors That Affect How Long It Stays
Your kidney function is the biggest variable. Since the kidneys are the only route for eliminating alendronate that doesn’t bind to bone, any reduction in kidney function means more drug accumulates in your skeleton and takes longer to leave. People with significant kidney impairment are generally not prescribed alendronate for this reason.
Your rate of bone turnover also plays a role. People with faster bone remodeling will release stored alendronate more quickly, while those with slower turnover (including people whose turnover has been suppressed by the drug itself) will retain it longer. Age, hormonal status, physical activity level, and other medications can all influence turnover rates. There’s no simple blood test that tells you exactly how much alendronate remains in your bones at any given time, but markers of bone turnover can give your doctor a rough sense of how actively your skeleton is remodeling and, by extension, how quickly it might be releasing stored drug.